Stay updated on Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page.

Latest updates to the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page
- Check6 days agoChange DetectedThe study page for NCT03642132 now displays a 403 Forbidden error, replacing the previous study record content with an access-denied message. As a result, the detailed study information, enrollment data, and location lists are no longer accessible on that page.SummaryDifference18%

- Check13 days agoChange DetectedDifference0.1%

- Check20 days agoChange DetectedAdded the topic 'Ovarian cancer' and a related topics entry 'MedlinePlus Genetics' to categorize the study and guide users to authoritative genetics resources.SummaryDifference0.1%

- Check27 days agoChange DetectedA new page revision tag, Revision: v3.6.6, was added. Several related-topic items (Ovarian cancer, MedlinePlus Genetics) and the 'related topics' header were removed.SummaryDifference0.1%

- Check34 days agoChange DetectedThe study's identifiers section now includes an NIH grant/contract entry (2017). This indicates funding associated with the trial.SummaryDifference0.0%

- Check48 days agoChange DetectedAdded related topics 'Ovarian cancer' and 'MedlinePlus Genetics' to the page's topics. Updated the site revision from v3.6.4 to v3.6.5.SummaryDifference0.1%

Stay in the know with updates to Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page.